Profound Medical (PROF) Reports Q3 Loss, Beats Revenue Estimates

Profound Medical reported a quarterly loss of $0.21 per share, missing the consensus estimate of $0.19 loss, with an earnings surprise of -10.53%. Revenue of $9.83 million slightly exceeded expectations by 0.31%, but the company has underperformed the S&P 500 by 21.3% year-to-date. Despite the miss, the stock maintains a Zacks Rank #2 (Buy) rating based on favorable estimate revision trends.